Our Board will still meet the holiday week of 4th of July. Please submit all documents and forms by end of day July 3rd for review in the July 12, 2012 regularly scheduled meeting. To discuss your upcoming study review needs, contact us at 317.899.9341 or email...
PharmaVOICE has featured Pearl Pathways twice in the last year. In January 2012, Pearl President and CEO, Diana Caldwell, shared her thoughts on the expansion of Pearl’s services to meet the growing needs of their customers. In April 2012, Chief Operating...
Pearl Pathways is excited to announce the recent hiring of J. Ellen Looney as an IRB administrator. Ellen is well experienced and has Pearl Pathways CEO, Diana Caldwell, excited to have her as part of the Pearl team, “Our staff and clients are lucky to have Ellen...
This event will be a great gathering for clinical research professionals. Gretchen Bowker, Pearl IRB COO is speaking at the event. The title of the event is: Ask the IRB’s- Answers might be different than what your IRB is telling you. Pearl will also be...
According to Ciaran Murray, the CEO of Icon, large-scale CRO consolidation will not be at the level of past years in 2012. According to Murray, the industry will take a step back and digest the moves from previous years, although companies will still be active in...
